Mycobacterium haemophilum infection in an SLE patient on mycophenolate mofetil
- 1 April 2002
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 11 (4) , 249-252
- https://doi.org/10.1191/0961203302lu175cr
Abstract
We describe a case of Mycobacterium haemophilum in an immunocompromised patient with systemic lupus erythematosus (SLE). Mycobacterium haemophilum is a recently described pathogen which has not been previously described either in SLE patients or patients on Mycophenolate Mofetil. Mycobacterium haemophilum can be difficult to diagnose, as it may not have the granulomas characteristic of atypical mycobacterial infections. Combination therapy with at least two drugs for several months is required and the outcome depends on the patient's underlying immunocompromised state. Our report highlights the need for early diagnosis and treatment of Mycobacterium haemophilum in immunocompromised patients with SLE.Keywords
This publication has 8 references indexed in Scilit:
- Treatment of systemic lupus erythematosus with mycophenolate mofetilLupus, 2001
- Cytomegalovirus Colitis during Mycophenolate Mofetil Therapy for Wegener’s GranulomatosisAmerican Journal of Nephrology, 2000
- Histologic Reactions to Cutaneous Infections by Mycobacterium haemophilumThe American Journal of Surgical Pathology, 1999
- INTESTINAL MICROSPORIDIOSIS OCCURRING IN TWO RENAL TRANSPLANT RECIPIENTS TREATED WITH MYCOPHENOLATE MOFETILTransplantation, 1999
- Arthritis and spondylodiscitis caused by Mycobacterium xenopi in a patient with systemic lupus erythematosusRheumatology, 1997
- Mycobacterium haemophilum: An emerging pathogenEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Disseminated Cutaneous and Synovial Mycobacterium marinum Infection in a Patient With Systemic Lupus ErythematosusSouthern Medical Journal, 1990
- Computer analysis of factors influencing frequency of infection in systemic lupus erythematosusArthritis & Rheumatism, 1978